C-reactive protein and atrial fibrillation: “Evidence for the presence of inflammation in the perpetuation of the arrhythmia”

Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham heart study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946 Lip, 1997, Hypercoagulability and haemodynamic abnormalities in atrial fibrillation, Heart, 77, 395, 10.1136/hrt.77.5.395 Lip, 1996, Fibrinogen and fibrin d-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis, Am Heart J, 131, 724, 10.1016/S0002-8703(96)90278-1 Mihm, 2001, Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation, Circulation, 104, 174, 10.1161/01.CIR.104.2.174 Bruins, 1997, Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia, Circulation, 96, 3542, 10.1161/01.CIR.96.10.3542 Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation, Circulation, 104, 2886, 10.1161/hc4901.101760 Dernellis, 2001, C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation, Acta Cardiol, 56, 375, 10.2143/AC.56.6.2005701 Kamiyama, 1998, Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model, Jpn Circ J, 62, 837, 10.1253/jcj.62.837 Roldan, 2003, Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation, Eur Heart J, 24, 1373, 10.1016/S0195-668X(03)00239-2 Rifai, 1999, Clinical efficacy of an automated high-sensitivity C-reactive protein assay, Clin Chem, 45, 2136, 10.1093/clinchem/45.12.2136 Gabay, 1999, Acute-phase proteins and other systemic responses to inflammation, N Engl J Med, 340, 448, 10.1056/NEJM199902113400607 Ross, 1999, Mechanisms of disease: atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401 Ridker, 2001, High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease, Circulation, 103, 1813, 10.1161/01.CIR.103.13.1813 Ridker, 2000, C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N Engl J Med, 342, 836, 10.1056/NEJM200003233421202 Morrow, 1998, C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction, J Am Coll Cardiol, 31, 1460, 10.1016/S0735-1097(98)00136-3 Lagrand, 1999, C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?, Circulation, 100, 96, 10.1161/01.CIR.100.1.96 Torzewski, 2000, C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis, Arterioscler Thromb Vasc Biol, 20, 2094, 10.1161/01.ATV.20.9.2094 Venugopal, 2002, Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells, Circulation, 106, 1439, 10.1161/01.CIR.0000033116.22237.F9 Aviles, 2003, Inflammation as a risk factor for atrial fibrillation, Circulation, 108, 3006, 10.1161/01.CIR.0000103131.70301.4F Dernellis, 2004, Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation, Eur Heart J, 25, 1100, 10.1016/j.ehj.2004.04.025 Stroke Prevention in Atrial Investigators, 1992, Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk, Ann Intern Med, 116, 1, 10.7326/0003-4819-116-1-1 Carnes, 2001, Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation, Circ Res, 89, E32, 10.1161/hh1801.097644 Di Napoli, 2002, Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients, Stroke, 33, 1763, 10.1161/01.STR.0000019124.54361.08 Conway, 2004, Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation, J Am Coll Cardiol, 43, 2075, 10.1016/j.jacc.2003.11.062